Where Helixera uses automation
Helixera uses software and AI-assisted workflows to collect source records, identify disease relevance, detect duplicates, classify categories, rank signals, create plain-language summaries, answer questions about selected trial records, and organize evidence workspaces.
Source grounding
Helixera is designed around provenance. Intelligence items and trial answers should be tied to source records that users can inspect. A citation does not guarantee that the summary is complete or that the underlying source is correct.
Human review
Helixera includes review-to-publish and editorial quality workflows. However, Helixera does not claim that a human reviews every automated record, summary, ranking, or answer before it appears.
Known limitations
Automated systems can hallucinate, omit context, merge distinct records, misclassify a disease or source, and reflect limitations in their training data or prompts. Source feeds can also be delayed or unavailable.
- Generated content should not be treated as medical advice.
- Trial eligibility and enrollment must be confirmed by the study team.
- Preprints have not necessarily completed peer review.
- Company announcements describe the company’s own claims and should be read in that context.
User controls
Users can open original sources, change filters, select a different trial, compare supported fields, save or remove watched items, and report a source or summary concern through Contact.
Safety direction
Helixera intentionally avoids generating personalized medical direction or suggested questions that could be interpreted as clinical advice. The product’s role is to make disease research movement visible and understandable while preserving the boundary between intelligence and care.